TTRX · Turn Therapeutics Inc.
$7.53
-0.17 (-2.21%)
At close · Jul 29
Going-concern doubt
— flagged May 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our capital resources may not be sufficient to fund operations through at least the next 12 months from the date that these unaudited condensed consolidated financial statements as of March 31, 2026 are issued based on our expected cash needs, which raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 11, 2026
Market Cap
$229.37M
Shares
29.79M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-28 | — | |
| 8-K | 2026-07-07 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-03 | — | |
| 8-K | 2026-06-01 | — | |
| 8-K | 2026-05-27 | — | |
| 8-K | 2026-05-19 | — | |
| 8-K | 2026-05-18 | — | |
| 8-K | 2026-05-11 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-03-31 | — | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-03-24 | 2026-03-23 | |
| 8-K | 2026-02-17 | — | |
| 8-K | 2026-02-09 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2025-11-13 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-12 | 2025-11-11 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-10-28 | 2025-10-27 | |
| 8-K | 2025-10-22 | — | |
| 8-K | 2025-10-02 | 2025-09-30 |
Showing 1–27 of 27 filings